Chronic U50,488H abolishes inositol 1,4,5-trisphosphate and intracellular Ca2+ elevations evoked by κ-opioid receptor in rat myocytes
The inositol 1,4,5-trisphosphate (IP3) content and intracellular free Ca2+ ([Ca2+]i) level in response to kappa-opioid receptor stimulation with selective kappa-opioid receptor agonists, dynorphin-(1-13) and trans-3,4-dichloro-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeacetamidel (U50,488H) were determine...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 1996-07, Vol.307 (3), p.323-329 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The inositol 1,4,5-trisphosphate (IP3) content and intracellular free Ca2+ ([Ca2+]i) level in response to kappa-opioid receptor stimulation with selective kappa-opioid receptor agonists, dynorphin-(1-13) and trans-3,4-dichloro-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeacetamidel (U50,488H) were determined in ventricular myocytes. Both IP3 and [Ca2+]i were increased following kappa-opioid receptor stimulation. The responses of IP3 and [Ca2+]i to kappa-opioid receptor stimulation were abolished in myocytes of rats that had received chronic injection of U50,488H for 4 days. kappa-Opioid receptor stimulation with U50,488H also reduced the [Ca2+]i transient, induced by electrical stimulation and caffeine, both known to mobilize [Ca2+]i. The effect was abolished after the myocytes had been incubated with U50,488H at a subthreshold concentration for its effect on [Ca2+]i for 24 h. The present study showed for the first time that, upon the development of tolerance to a kappa-opioid receptor agonist, the responses of IP3 and [Ca2+]i to kappa-opioid receptor stimulation were abolished. The lack of response in [Ca2+]i was due to a failure of mobilization of Ca2+ from its intracellular pool. Further study is needed to determine the events that occur after the kappa-opioid receptor stimulation to production of IP3 upon the development of tolerance to a kappa-opioid. |
---|---|
ISSN: | 0014-2999 1879-0712 |
DOI: | 10.1016/0014-2999(96)00280-4 |